Lipid biology of breast cancer

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 10, 2013, Pages 1509-1517

  Baumann, Jan ^a   Sevinsky, Christopher ^a   Conklin, Douglas S ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Breast cancer; HER2 neu; Metabolism; Signaling

Indexed keywords

ACETYL COENZYME A; ACETYL COENZYME A CARBOXYLASE; CHEMICAL COMPOUND; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; FATTY ACID; GESTAGEN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HORMONE SENSITIVE LIPASE; INSULIN; LIPID; LIVER X RECEPTOR ALPHA; LONG CHAIN FATTY ACID COENZYME A LIGASE; MYRISTIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; S6 KINASE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR FKHR; TRIACYLGLYCEROL LIPASE; X BOX BINDING PROTEIN 1;

ACYLATION; ADIPOCYTE; ADIPOGENESIS; ALCOHOL CONSUMPTION; BODY MASS; BREAST CANCER; CALORIC INTAKE; CANCER SURVIVAL; CELL PROLIFERATION; CELLULAR DISTRIBUTION; ENDOPLASMIC RETICULUM STRESS; ENERGY EXPENDITURE; ESTROGEN BLOOD LEVEL; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; FATTY LIVER; GENE EXPRESSION; GLUCOSE TOLERANCE; HISTONE ACETYLATION; HUMAN; INSULIN SENSITIVITY; LIPID LIVER LEVEL; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; NONHUMAN; OBESITY; PALMITOYLATION; PORCUPINE; PRENYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SURVIVAL RATE; TRANSCRIPTION INITIATION; TRIPLE NEGATIVE BREAST CANCER; WNT SIGNALING PATHWAY; BIOSYNTHESIS; BREAST TUMOR; COMPLICATION; FEMALE; METABOLISM; PATHOLOGY;

BREAST NEOPLASMS; FATTY ACIDS; FEMALE; HUMANS; LIPID METABOLISM; OBESITY;

EID: 84885175060     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2013.03.011     Document Type: Review

References (125)

1. M. Laplante, D.M. Sabatini, An emerging role of mTOR in lipid biosynthesis, Curr. Biol. 19 (2009) R1046-R1052.
2. LC. Foukas, D.J. Withers, Phosphoinositide signalling pathways in metabolic regulation, Curr. Top. Microbiol. Immunol. 346 (2010) 115-141.
3. E.L. Whiteman, H. Cho, M.J. Birnbaum, Role of Akt/protein kinase B in metabolism, Trends Endocrinol. Metab. 13 (2002) 444-451. (Pubitemid 36733939)
4. C.L. Buller, R.D. Loberg, M.H. Fan, Q. Zhu, J.L. Park, E. Vesely, K. Inoki, K.L. Guan, F.C. Brosius III, A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression, Am. J. Physiol. Cell Physiol. 295 (2008) C836-C843.
5. J.A. Menendez, Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives, Biochim. Biophys. Acta 1801 (2010) 381-391.
6. A. Kourtidis, R. Jain, R.D. Carkner, C. Eifert, M.J. Brosnan, D.S. Conklin, An RNA interference screen identifies metabolic regulators NR1 D1 and PBP as novel survival factors for breast cancer cells with the ERBB2 signature, Cancer Res. 70 (2010) 1783.
7. A. Kourtidis, R. Srinivasaiah, R.D. Carkner, M.J. Brosnan, D.S. Conklin, Peroxisome proliferator-activated receptor-gamma protects ERBB2-positive breast cancer cells from palmitate toxicity, Breast Cancer Res. 11 (2009) R16.
8. JA Menendez, L Vellon, I. Mehmi, B.P. Oza, S. Ropero, R Colomer, R. Lupu, Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells, Proc Natl. Acad. Sci. U. S. A. 101 (2004) 10715-10720. (Pubitemid 38955808)
9. A. Vazquez-Martin, R. Colomer, J. Brunet, JA Menendez, Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb1 00 breast cancer cells, Int J. Oncol. 31 (2007) 769-776.
10. J. Lessig, B. Fuchs, Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis, Curr. Med. Chem. 16 (2009) 2021-2041.
11. S.T. Pruett, A. Bushnev, K. Hagedorn, M. Adiga, Ca. Haynes, M.C. Sullards, D.C. Liotta, A.H. Merrill, Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols, J. Lipid Res. 49 (2008) 1621-1639.
12. M.S. Bretscher, Asymmetrical lipid bilayer structure for biological membranes, Nat New Biol. 236 (1972) 11-12.
13. A. Ibrahimi, Z. Sfeir, Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport, Proc. Natl. Acad. Sci. 93 (1996) 2646-2651. (Pubitemid 26114302)
14. Y. Ge, M. Elghetany, CD36: a multiligand molecule, Lab. Hematol. 11 (2005) 31-37. (Pubitemid 40444030)
15. J. Ellis, J. Frahm, Acyl-coenzyme A synthetases in metabolic control, Curr. Opin. Cell Biol. 21 (2010) 212-217.
16. M.G. Vander Heiden, L.C. Cantley, C.B. Thompson, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science 324 (2009) 1029-1033.
17. J.E. Schaffer, Lipotoxicity: when tissues overeat, Curr. Opin. Lipidol. 14 (2003) 281-287. (Pubitemid 36688207)
18. R. Leonardi, Y.-m. Zhang, CO. Rock, S. Jackowski, Coenzyme A: back in action, Prog. Lipid Res. 44 (2005) 125-153. (Pubitemid 40733082)
19. O. Breus, G. Panasyuk, I.T. Gout, V. Filonenko, I. Nemazanyy, CoA synthase is in complex with p85alphaPI3K and affects PI3K signaling pathway, Biochem. Biophys. Res. Commun. 385 (2009) 581-585.
20. I. Nemazanyy, G. Panasyuk, A. Zhyvoloup, G. Panayotou, I.T. Gout, V. Filonenko, Specific interaction between S6K1 and CoA synthase: a potential link between the mTOR/S6K pathway, CoA biosynthesis and energy metabolism, FEBS Lett. 578 (2004) 357-362. (Pubitemid 39601806)
21. B.N. Albaugh, K.M. Arnold, J.M. Denu, KAT(ching) metabolism by the tail: insight into the links between lysine acetyltransferases and metabolism, Chembiochem 12 (2011) 290-298.
22. K.E. Wellen, G. Hatzivassiliou, U.M. Sachdeva, T.V. Bui, J.R. Cross, C.B. Thompson, ATP-citrate lyase links cellular metabolism to histone acetylation, Science (New York, N.Y.) 324 (2009) 1076-1080.
23. S. Zhao, W. Xu, W. Jiang, W. Yu, Y. Lin, T. Zhang, J. Yao, L. Zhou, Y. Zeng, H. Li, Y. Li, J. Shi, W. An, S.M. Hancock, F. He, L. Qin, J. Chin, P. Yang, X. Chen, Q. Lei, Y. Xiong, K.-L. Guan, Regulation of cellular metabolism by protein lysine acetylation, Science (New York, N.Y.) 327 (2010) 1000-1004.
24. D. Chalbos, M. Chambon, Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells, J. Biol. Chem. 262 (1987) 9923-9926.
25. F. Kuhajda, K. Jenner, Fatty acid synthesis: a potential selective target for antineoplastic therapy, Proc. Natl. Acad. Sci. 91 (1994) 6379-6383. (Pubitemid 24200664)
26. A. Vazquez-Martin, R. Colomer, J. Brunet, R. Lupu, JA Menendez, Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells, Cell Prolif. 41 (2008) 59-85. (Pubitemid 351147647)
27. Q. Jin, L.X. Yuan, D. Boulbes, J.M. Baek, Y.N. Wang, D. Gomez-Cabello, D.H. Hawke, S.C Yeung, M.H. Lee, G.N. Hortobagyi, M.C. Hung, F.J. Esteva, Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells, Breast Cancer Res. 12 (2010) R96.
28. L.L. Listenberger, X. Han, S.E. Lewis, S. Cases, R.V. Farese, D.S. Ory, J.E. Schaffer, Triglyceride accumulation protects against fatty acid-induced lipotoxicity, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3077-3082. (Pubitemid 36356542)
29. P. Kauraniemi, M. Bärlund, O. Monni, A. Kallioniemi, New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays, Cancer Res. 61 (2001) 8235-8240. (Pubitemid 33091617)
30. B.B. Lowell, PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function, Cell 99 (1999) 239-242. (Pubitemid 29519902)
31. Y. Zhu, C. Qi, S. Jain, M.S. Rao, J.K. Reddy, Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor, J. Biol. Chem. 272 (1997) 25500-25506. (Pubitemid 27438856)
32. Y. Yang, P.J. Morin, W.F. Han, T. Chen, D.M. Bornman, E.W. Gabrielson, E.S. Pizer, Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c, Exp. Cell Res. 282 (2003) 132-137. (Pubitemid 36259906)
33. S. Yoon, M.-Y. Lee, S.W. Park, J.-S. Moon, Y.-K. Koh, Y.-H. Ahn, B.-W. Park, K.-S. Kim, Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells, J. Biol. Chem. 282 (2007) 26122-26131. (Pubitemid 47443806)
34. P. Ferre, F. Foufelle, SREBP-1c transcription factor and lipid homeostasis: clinical perspective, Horm. Res. 68 (2007) 72-82. (Pubitemid 47026704)
35. Y. Kamei, S. Miura, T. Suganami, F. Akaike, S. Kanai, S. Sugita, A. Katsumata, H. Aburatani, T.G. Unterman, O. Ezaki, Y. Ogawa, Regulation of SREBP1c gene expression in skeletal muscle: role of retinoid X receptor/liver X receptor and forkhead-O1 transcription factor, Endocrinology 149 (2008) 2293-2305. (Pubitemid 351577397)
36. P.K. Vogt, H. Jiang, M. Aoki, Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins, Cell Cycle 4 (2005) 908-913. (Pubitemid 41359756)
37. F. Wang, Q. Tong, SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma, Mol. Biol. Cell 20 (2009) 801-808.
38. A.D. Kohn, S.A. Summers, M.J. Birnbaum, R.A. Roth, Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation, J. Biol. Chem. 271 (1996) 31372-31378. (Pubitemid 26408588)
39. X.D. Peng, P.Z. Xu, M.L. Chen, A. Hahn-Windgassen, J. Skeen, J. Jacobs, D. Sundararajan, W.S. Chen, S.E. Crawford, K.G. Coleman, N. Hay, Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2, Genes Dev. 17 (2003) 1352-1365. (Pubitemid 36666005)
40. R.B. Rawson, The SREBP pathway-insights from Insigs and insects, Nat. Rev. Mol. Cell Biol. 4 (2003) 631-640.
41. S. Li, M.S. Brown, J.L. Goldstein, Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis, Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 3441-3446.
42. T. Porstmann, C.R. Santos, B. Griffiths, M. Cully, M. Wu, S. Leevers, J.R. Griffiths, Y.L. Chung, A. Schulze, SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth, Cell Metab. 8 (2008) 224-236.
43. T.R. Peterson, S.S. Sengupta, T.E. Harris, A.E. Carmack, S.A. Kang, E. Balderas, D.A. Guertin, K.L. Madden, A.E. Carpenter, B.N. Finck, D.M. Sabatini, mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway, Cell 146 (2011) 408-420.
44. B.N. Finck, M.C. Gropler, Z. Chen, T.C. Leone, M.A. Croce, T.E. Harris, J.C. Lawrence Jr., D.P. Kelly, Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway, Cell Metab. 4 (2006) 199-210. (Pubitemid 44283957)
45. K. Hong, L. Lou, S. Gupta, F. Ribeiro-Neto, D.L. Altschuler, A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation, J. Biol. Chem. 283 (2008) 23129-23138.
46. K. Reue, D.N. Brindley, Thematic review series: glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism, J. Lipid Res. 49 (2008) 2493-2503.
47. D.A. Foster, Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells, Biochim. Biophys. Acta 1791 (2009) 949-955.
48. J. Brunet, A. Vazquez-Martin, R. Colomer, B. Graña-Suarez, B. Martin-Castillo, J.A. Menendez, BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer, Mol. Carcinog. 47 (2008) 157-163. (Pubitemid 351231444)
49. C. Magnard, R. Bachelier, A. Vincent, M. Jaquinod, S. Kieffer, G.M. Lenoir, N.D. Venezia, BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains, Oncogene 21 (2002) 6729-6739. (Pubitemid 35221915)
50. K. Moreau, E. Dizin, H. Ray, C. Luquain, E. Lefai, F. Foufelle, M. Billaud, G.M. Lenoir, N.D. Venezia, BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase, J. Biol. Chem. 281 (2006) 3172-3181. (Pubitemid 43845927)
51. K.E.N. Scott, F.B. Wheeler, A.L. Davis, M.J. Thomas, J.M. Ntambi, D.F. Seals, S.J. Kridel, Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis, PLoS One 7 (2012) e29761.
52. V. Chajès, M. Cambot, K. Moreau, G.M. Lenoir, V. Joulin, Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival, Cancer Res. 66 (2006) 5287-5294. (Pubitemid 43844953)
53. R. Flavin, S. Peluso, P.L. Nguyen, M. Loda, Fatty acid synthase as a potential therapeutic target in cancer, Future Oncol. 6 (2010) 551-562.
54. H. Malhi, R.J. Kaufman, Endoplasmic reticulum stress in liver disease, J. Hepatol. 54 (2011) 795-809.
55. R. Sriburi, S. Jackowski, K. Mori, J.W. Brewer, XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum, J. Cell Biol. 167 (2004) 35-41. (Pubitemid 39363412)
56. S.J. Healy, A.M. Gorman, P. Mousavi-Shafaei, S. Gupta, A. Samali, Targeting the endoplasmic reticulum-stress response as an anticancer strategy, Eur. J. Pharmacol. 625 (2009) 234-246.
57. C. de Haro, R. Mendez, J. Santoyo, The eIF-2alpha kinases and the control of protein synthesis, FASEB J. 10 (1996) 1378-1387. (Pubitemid 26347872)
58. S.R. Kimball, Eukaryotic initiation factor eIF2, Int. J. Biochem. Cell Biol. 31 (1999) 25-29. (Pubitemid 29094786)
59. K. Lee, W. Tirasophon, X. Shen, M. Michalak, R. Prywes, T. Okada, H. Yoshida, K. Mori, R.J. Kaufman, IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response, Genes Dev. 16 (2002) 452-466. (Pubitemid 34165102)
60. H. Yoshida, T. Okada, K. Haze, H. Yanagi, T. Yura, M. Negishi, K. Mori, ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response, Mol. Cell. Biol. 20 (2000) 6755-6767.
61. H. Zinszner, M. Kuroda, X. Wang, N. Batchvarova, R.T. Lightfoot, H. Remotti, J.L. Stevens, D. Ron, CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum, Genes Dev. 12 (1998) 982-995. (Pubitemid 28204605)
62. S.M. Colgan, D. Tang, G.H. Werstuck, R.C. Austin, Endoplasmic reticulum stress causes the activation of sterol regulatory element binding protein-2, Int. J. Biochem. Cell Biol. 39 (2007) 1843-1851. (Pubitemid 47321345)
63. J.N. Lee, J. Ye, Proteolytic activation of sterol regulatory element-binding protein induced by cellular stress through depletion of Insig-1, J. Biol. Chem. 279 (2004) 45257-45265. (Pubitemid 39430941)
64. D.T. Rutkowski, J. Wu, S.H. Back, M.U. Callaghan, S.P. Ferris, J. Iqbal, R. Clark, H. Miao, J.R. Hassler, J. Fornek, M.G. Katze, M.M. Hussain, B. Song, J. Swathirajan, J. Wang, G.D. Yau, R.J. Kaufman, UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators, Dev. Cell 15 (2008) 829-840.
65. U. Ozcan, L. Ozcan, E. Yilmaz, K. Duvel, M. Sahin, B.D. Manning, G.S. Hotamisligil, Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis, Mol. Cell 29 (2008) 541-551. (Pubitemid 351384644)
66. H. Sha, Y. He, H. Chen, C. Wang, A. Zenno, H. Shi, X. Yang, X. Zhang, L. Qi, The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis, Cell Metab. 9 (2009) 556-564.
67. A.-H. Lee, E.F. Scapa, D.E. Cohen, L.H. Glimcher, Regulation of hepatic lipogenesis by the transcription factor XBP1, Science (New York, N.Y.) 320 (2008) 1492-1496. (Pubitemid 351929428)
68. S. Oyadomari, H.P. Harding, Y. Zhang, M. Oyadomari, D. Ron, Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice, Cell Metab. 7 (2008) 520-532. (Pubitemid 351729207)
69. R. Sriburi, H. Bommiasamy, G.L. Buldak, G.R. Robbins, M. Frank, S. Jackowski, J.W. Brewer, Coordinate regulation of phospholipid biosynthesis and secretory pathway gene expression in XBP-1(S)-induced endoplasmic reticulum biogenesis, J. Biol. Chem. 282 (2007) 7024-7034. (Pubitemid 47093662)
70. E. Bobrovnikova-Marjon, G. Hatzivassiliou, C. Grigoriadou, M. Romero, D.R. Cavener, C.B. Thompson, J.A. Diehl, PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 16314-16319.
71. J. Lee, R. Mendez, H. Heng, Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation, Am. J. Transl. Res. 4 (2012) 102-113.
72. H.L. Kammoun, H. Chabanon, I. Hainault, S. Luquet, C. Magnan, T. Koike, P. Ferre, F. Foufelle, GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice, J. Clin. Invest. 119 (2009) 1201-1215.
73. B.G. Wouters, M. Koritzinsky, Hypoxia signalling through mTOR and the unfolded protein response in cancer, Nat. Rev. Cancer 8 (2008) 851-864.
74. P. Chakrabarti, T. English, J. Shi, C.M. Smas, K.V. Kandror, Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage, Diabetes 59 (2010) 775-781.
75. G.A. Soliman, H.A. Acosta-Jaquez, D.C. Fingar, mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes, Lipids 45 (2010) 1089-1100.
76. L.C. Cantley, The phosphoinositide 3-kinase pathway, Science 296 (2002) 1655-1657. (Pubitemid 34579158)
77. M. Laplante, D.M. Sabatini, mTOR signaling in growth control and disease, Cell 149 (2012) 274-293.
78. E.J. McManus, B.J. Collins, P.R. Ashby, A.R. Prescott, V. Murray-Tait, L.J. Armit, J.S. Arthur, D.R. Alessi, The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation, EMBO J. 23 (2004) 2071-2082. (Pubitemid 38737734)
79. D.R. Alessi, M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, B.A. Hemmings, Mechanism of activation of protein kinase B by insulin and IGF-1, EMBO J. 15 (1996) 6541-6551. (Pubitemid 26413787)
80. C.C. Thomas, M. Deak, D.R. Alessi, D.M. van Aalten, High-resolution structure of the pleckstrin homology domain of protein kinase b/akt bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr. Biol. 12 (2002) 1256-1262. (Pubitemid 34801176)
81. D.D. Sarbassov, D.A. Guertin, S.M. Ali, D.M. Sabatini, Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex, Science 307 (2005) 1098-1101. (Pubitemid 40262113)
82. W.J. Oh, C.C. Wu, S.J. Kim, V. Facchinetti, L.A. Julien, M. Finlan, P.P. Roux, B. Su, E. Jacinto, mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide, EMBO J. 29 (2010) 3939-3951.
83. T. Holbro, R.R. Beerli, F. Maurer, M. Koziczak, C.F. Barbas III, N.E. Hynes, The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8933-8938. (Pubitemid 36899201)
84. Comprehensive molecular portraits of human breast tumours, Nature 490 (2012) 61-70.
85. A.R. Tee, R. Anjum, J. Blenis, Inactivation of the tuberous sclerosis rapamycin complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/ Akt-dependent and -independent phosphorylation of tuberin, J. Biol. Chem. 278 (2003) 37288-37296. (Pubitemid 37175245)
86. R. Zoncu, A. Efeyan, D.M. Sabatini, mTOR: from growth signal integration to cancer, diabetes and ageing, Nat. Rev. Mol. Cell Biol. 12 (2011) 21-35.
87. Y. Sun, Y. Fang, M.S. Yoon, C. Zhang, M. Roccio, F.J. Zwartkruis, M. Armstrong, H.A. Brown, J. Chen, Phospholipase D1 is an effector of Rheb in the mTOR pathway, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 8286-8291. (Pubitemid 351904748)
88. V. Veverka, T. Crabbe, I. Bird, G. Lennie, F.W. Muskett, R.J. Taylor, M.D. Carr, Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR, Oncogene 27 (2008) 585-595. (Pubitemid 351158903)
89. A. Toschi, E. Lee, L. Xu, A. Garcia, N. Gadir, D.A. Foster, Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin, Mol. Cell. Biol. 29 (2009) 1411-1420.
90. C. Aicart-Ramos, R.A. Valero, I. Rodriguez-Crespo, Protein palmitoylation and subcellular trafficking, Biochim. Biophys. Acta 1808 (2011) 2981-2994.
91. K.A. Cadwallader, H. Paterson, S.G. Macdonald, J.F. Hancock, N-terminally myristoylated Ras proteins require palmitoylation or a polybasic domain for plasma membrane localization, Mol. Cell. Biol. 14 (1994) 4722-4730. (Pubitemid 24196822)
92. I. Sato, Y. Obata, K. Kasahara, Y. Nakayama, Y. Fukumoto, T. Yamasaki, K.K. Yokoyama, T. Saito, N. Yamaguchi, Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain, J. Cell Sci. 122 (2009) 965-975.
93. E. Bilal, G. Alexe, M. Yao, L. Cong, A. Kulkarni, V. Ginjala, D. Toppmeyer, S. Ganesan, G. Bhanot, Identification of the YES1 Kinase as a therapeutic target in basal-like breast cancers, Genes Cancer 1 (2010) 1063-1073.
94. V. Yadav, M.F. Denning, Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration, Mol. Carcinog. 50 (2011) 346-352.
95. J.C. Montero, S. Seoane, A. Ocaña, A. Pandiella, Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors, Clin. Cancer Res. 17 (2011) 5546-5552.
96. C. Byrne, L. Khemtémourian, V. Pelekanou, M. Kampa, G. Leclercq, S. Sagan, E. Castanas, F. Burlina, Y. Jacquot, ERα17p, a peptide reproducing the hinge region of the estrogen receptor α associates to biological membranes: a biophysical approach, Steroids 77 (2012) 979-987.
97. D. Rai, A. Frolova, J. Frasor, A.E. Carpenter, B.S. Katzenellenbogen, Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells, Mol. Endocrinol. 19 (2005) 1606-1617. (Pubitemid 41002989)
98. M. Razandi, A. Pedram, E.R. Levin, Heat shock protein 27 is required for sex steroid receptor trafficking to and functioning at the plasma membrane, Mol. Cell. Biol. 30 (2010) 3249-3261.
99. O. Rocks, M. Gerauer, N. Vartak, S. Koch, Z.-P. Huang, M. Pechlivanis, J. Kuhlmann, L. Brunsveld, A. Chandra, B. Ellinger, H. Waldmann, P.I.H. Bastiaens, The palmitoylation machinery is a spatially organizing system for peripheral membrane proteins, Cell 141 (2010) 458-471.
100. J.M. Draper, C.D. Smith, DHHC20: a human palmitoyl acyltransferase that causes cellular transformation, Mol. Membr. Biol. 27 (2010) 123-136.
101. T.M. Covey, S. Kaur, T. Tan Ong, K.D. Proffitt, Y. Wu, P. Tan, D.M. Virshup, PORCN moonlights in a Wnt-independent pathway that regulates cancer cell proliferation, PLoS One 7 (2012) e34532.
102. E. Calle, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults, N. Engl. J. Med. 348 (2003) 1625-1638. (Pubitemid 36459468)
103. V. Rosato, C. Bosetti, R. Talamini, F. Levi, M. Montella, A. Giacosa, E. Negri, C. La Vecchia, Metabolic syndrome and the risk of breast cancer in postmenopausal women, Ann. Oncol. 22 (2011) 2687-2692.
104. M. Marmot, T. Atinmo, T. Byers, J. Chen, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, 2007, p. 292-295.
105. B.R. Goldin, M.N. Woods, D.L. Spiegelman, C. Longcope, A. Morrill-LaBrode, J.T. Dwyer, L.J. Gualtieri, E. Hertzmark, S.L. Gorbach, The effect of dietary fat and fiber on serum estrogen concentrations in premenopausal women under controlled dietary conditions, Cancer 74 (1994) 1125-1131. (Pubitemid 24232010)
106. M. Protani, M. Coory, J.H. Martin, Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis, Breast Cancer Res. Treat. 123 (2010) 627-635.
107. A.I. Phipps, D.S.M. Buist, K.E. Malone, W.E. Barlow, P.L Porter, K. Kerlikowske, E.S. O'Meara, C.I. Li, Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer, Ann. Epidemiol. 22 (2012) 340-348.
108. M. Pierobon, C.L Frankenfeld, Obesity as a Risk Factor for Triple-negative Breast Cancers: a Systematic Review and Meta-analysis, Breast Cancer Res. Treat 137 (1) (2013) 307-314.
109. C.C.J. Creighton, Y.H.Y. Sada, Y. Zhang, A. Tsimelzon, H. Wong, B. Dave, M.D. Landis, H.D. Bear, A. Rodriguez, J.C. Chang, A gene transcription signature of obesity in breast cancer, Breast Cancer Res. Treat 132 (2012) 993-1000.
110. C.J. Creighton, A. Casa, Z. Lazard, S. Huang, A. Tsimelzon, S.G. Hilsenbeck, CK. Osborne, A.V. Lee, Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis, J. Clin. Oncol. 26 (2008) 4078-4085.
111. M.-K. Sung, J.-Y. Yeon, S.-Y. Park, J.H.Y. Park, M.-S. Choi, Obesity-induced metabolic stresses in breast and colon cancer, Ann. N. Y. Acad. Sci. 1229 (2011) 61-68.
112. E.E. Calle, M.J. Thun, Obesity and cancer, Oncogene 23 (2004) 6365-6378. (Pubitemid 39265505)
113. R. Kaaks, Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7 (1996) 605-625. (Pubitemid 26377730)
114. M.P. Madigan, R. Troisi, N. Potischman, J.F. Dorgan, LA Brinton, R.N. Hoover, Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States), Cancer Causes Control 9 (1998) 199-207. (Pubitemid 28160975)
115. M.P. Cleary, M.E. Grossmann, A. Ray, Effect of obesity on breast cancer development, Vet Pathol. 47 (2010) 202-213.
116. M. Bi, C. Naczki, M. Koritzinsky, D. Fels, J. Blais, N. Hu, H. Harding, I. Novoa, M. Varia, J. Raleigh, D. Scheuner, R.J. Kaufman, J. Bell, D. Ron, B.G. Wouters, C. Koumenis, ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth, EMBO J. 24 (2005) 3470-3481. (Pubitemid 41486784)
117. C. Koumenis, B.G. Wouters, "Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways, Mol. Cancer Res. 4 (2006) 423-436. (Pubitemid 44197038)
118. P. Scriven, S. Coulson, R. Haines, S. Balasubramanian, S. Cross, L. Wyld, Activation and clinical significance of the unfolded protein response in breast cancer, Br. J. Cancer 101 (2009) 1692-1698.
119. L.M. Wang, M.G. Myers Jr., X.J. Sun, S.A. Aaronson, M. White, J.H. Pierce, IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells, Science 261 (1993) 1591-1594. (Pubitemid 23319604)
120. O. Warburg, F. Wind, E. Negelein, The metabolism of tumors in the body, J. Gen. Physiol. 8 (1927) 519-530.
121. R. Bravo, T. Gutierrez, F. Paredes, D. Gatica, A.E. Rodriguez, Z. Pedrozo, M. Chiong, V. Parra, A.F. Quest, B.A. Rothermel, S. Lavandero, Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics, Int. J. Biochem Cell Biol. 44 (2012) 16-20.
122. T. Hayashi, R. Rizzuto, G. Hajnoczky, T.P. Su, MAM: more than just a housekeeper, Trends Cell Biol. 19 (2009) 81-88.
123. P. Polak, M.N. Hall, mTOR and the control of whole body metabolism, Curr. Opin. Cell Biol. 21 (2009) 209-218.
124. L. Khamzina, A. Veilleux, S. Bergeron, A. Marette, Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance, Endocrinology 146 (2005) 1473-1481. (Pubitemid 40289337)
125. A. Nagelkerke, J. Bussink, H. Mujcic, B.G. Wouters, S. Lehmann, F.C. Sweep, P.N. Span, Hypoxia stimulates migration of breast cancer cells via the PERK/ ATF4/LAMP3-arm of the unfolded protein response, Breast Cancer Res. 15 (2013) R2.